SlideShare a Scribd company logo
Case Study on
Carbamazepine Poisoning
Neeraj Ojha
Yuvraj Kalathoki
7th sem BPHARM
INTRODUCTION
Carbamazepine is a commonly prescribed agent for local epilepsy and other non
epileptic conditions such as neuropathic pain ,schizophrenia and bipolar disorder
in the pediatric and adult patients.
It is an anticonvulsant medication used primarily in the treatment of epilepsy and
neuropathic pain.
The first overdose of carbamazepine was reported in 1967,and significant toxicity
occurs at levels higher than 40 mg/L(usual therapeutic levels are 4 to 12 mg/L).
Common etiology for carbamazepine toxicity is coadministration of other
medications.
Route of exposure
Ingestion of the drug in large doses (drug overdose).
Symptoms /Clinical features
● Drowsiness
● Slurred speech
● Ataxia
● Hallucinations
● Nausea and Vomiting
● Tremors
● Seizures
● Oliguria
● Blurred vision
Mechanism of toxicity
Carbamazepine and its active metabolite causes sodium channel
blockade,causing slowed impulses in the brain .<
It binds preferentially to voltage-gated sodium channel in their inactive
conformation, which prevents repetitive and sustained firing of action potential.
Etiology of toxicity
Carbamazepine toxicity may result from acute overdose or chronic therapy .<
Therapeutic levels are 4-12 mg/L
Drug drug interaction are known to occur . Vander et al reported a case of
carbamazepine toxicity that occurred after administration of oxybutynin and an
increase in the dose of dantrolene. [9] The combination of these drugs elevated the
level of carbamazepine, leading to toxicity.
Treatment and Management
Prehospital care/General management:
● Perform ABCD (Airway, Breathing, Circulation and Disability);
● Obtain intravenous (IV) access
● Place the patient on a cardiac monitor .
● Administer IV fluids if the patient is hypotensive .
● Administer activated charcoal if the patient has intact mental status
and is able to protect the airway .
Contd.
Emergency Department care/Specific management for Chronic poisoning:
● Activated charcoal (if presents within 1 hour of ingestion).<
● Gastric lavage; Perform Gastric decontamination by
Diuresis/Dialysis/Haemoperfusion/Peritoneal dialysis;
CASE STUDY
Detailed case study
A 40 year male patient was referred to the emergency department of the
hospital.He was admitted due to the ingestion of unknown pharmaceutical agent in
an suicide attempt .THe patient has past medical history of epilepsy treated with
carbamazepine and oxcarbazepine.The patient was in coma ,occasionally
performing involuntary movements with his head arm and legs.
Route of exposure
Ingestion was the route through which toxic substance entered into the body.<
Subjective detail
● Gender - male
● Age -40 yrs old
● Weight -65kg
● Hospital: XYZ
Objective detail
The normal range of carbamazepine is 4-12 mg/L.(therapeutic level).<
The level of carbamazepine in patient was > 20ug/ml.<
The patient was subjected to hemodialysis.The patient underwent a 4 hour
hemoperfusion session followed by a hemodialysis session of 4 hour .
Assessment
The patient was diagnosed for the normal carbamazepine levels.<
Hemoperfusion followed by hemodialysis was done to totally clear the high levels
of carbamazepine.( 2 times the process was repeated).
Planning
● Gastrointestinal decontamination with activated charcoal is commonly used.
● Hemoperfusion followed by hemodialysis was performed in combination.
● Supportive measures are to be considered.
● Symptomatic treatments are to be performed as soon as the patient reaches
the hospital.
Suggestions
1. Study suggests that dialysis techniques can be beneficial in a case of severe
carbamazepine poisoning.<

More Related Content

What's hot

Haldol education 2014
Haldol education 2014Haldol education 2014
Haldol education 2014
dhexel
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
Annie Mirza
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
Jijo G John
 

What's hot (20)

Haldol education 2014
Haldol education 2014Haldol education 2014
Haldol education 2014
 
Mania
ManiaMania
Mania
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Adrenaline pharmacology
Adrenaline pharmacologyAdrenaline pharmacology
Adrenaline pharmacology
 
Pathophysiology and management of epilepsy
Pathophysiology and management of epilepsyPathophysiology and management of epilepsy
Pathophysiology and management of epilepsy
 
Parkinson's
Parkinson'sParkinson's
Parkinson's
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Antipsychotic drugs ppt
Antipsychotic drugs pptAntipsychotic drugs ppt
Antipsychotic drugs ppt
 
Carbamazepine.pptx
Carbamazepine.pptxCarbamazepine.pptx
Carbamazepine.pptx
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 
Hypoglycemic agents
Hypoglycemic agentsHypoglycemic agents
Hypoglycemic agents
 
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
 
Antidepressant drugs
Antidepressant drugsAntidepressant drugs
Antidepressant drugs
 
chlorpromazine(Antipsychotic Drug)
chlorpromazine(Antipsychotic Drug)chlorpromazine(Antipsychotic Drug)
chlorpromazine(Antipsychotic Drug)
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Benzodiazepines
BenzodiazepinesBenzodiazepines
Benzodiazepines
 
EPILEPSY
EPILEPSYEPILEPSY
EPILEPSY
 
Dopamine
DopamineDopamine
Dopamine
 

Similar to Carbamazepine

atypical antipsychoticsvgggggghhhhhh.pptx
atypical antipsychoticsvgggggghhhhhh.pptxatypical antipsychoticsvgggggghhhhhh.pptx
atypical antipsychoticsvgggggghhhhhh.pptx
drmariamyehia
 

Similar to Carbamazepine (20)

NOVEL DRUGS FOR TREATMENT OF SEIZURE.pptx
NOVEL DRUGS FOR TREATMENT OF SEIZURE.pptxNOVEL DRUGS FOR TREATMENT OF SEIZURE.pptx
NOVEL DRUGS FOR TREATMENT OF SEIZURE.pptx
 
Acute Poisoning edited.pptx
Acute Poisoning edited.pptxAcute Poisoning edited.pptx
Acute Poisoning edited.pptx
 
carbamazepine.pptx
carbamazepine.pptxcarbamazepine.pptx
carbamazepine.pptx
 
carbamazepinepublic-121124195050-phpapp01.pdf
carbamazepinepublic-121124195050-phpapp01.pdfcarbamazepinepublic-121124195050-phpapp01.pdf
carbamazepinepublic-121124195050-phpapp01.pdf
 
Anti epilepsy
Anti epilepsyAnti epilepsy
Anti epilepsy
 
Bipolar disorder
Bipolar disorderBipolar disorder
Bipolar disorder
 
Refractory status epilipticus
Refractory status epilipticusRefractory status epilipticus
Refractory status epilipticus
 
atypical antipsychoticsvgggggghhhhhh.pptx
atypical antipsychoticsvgggggghhhhhh.pptxatypical antipsychoticsvgggggghhhhhh.pptx
atypical antipsychoticsvgggggghhhhhh.pptx
 
Alprazolam
Alprazolam Alprazolam
Alprazolam
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Long acting injections in schizophrenia- an overview and Indian scenario (19...
Long acting injections in schizophrenia- an overview and Indian scenario  (19...Long acting injections in schizophrenia- an overview and Indian scenario  (19...
Long acting injections in schizophrenia- an overview and Indian scenario (19...
 
Drug Profile: Aripiprazole
Drug Profile: AripiprazoleDrug Profile: Aripiprazole
Drug Profile: Aripiprazole
 
Common drug and plant poisoning
Common drug and plant poisoningCommon drug and plant poisoning
Common drug and plant poisoning
 
Case Study on Paracetamol toxicity
Case Study on Paracetamol toxicityCase Study on Paracetamol toxicity
Case Study on Paracetamol toxicity
 
antiepilepticdrugs2-230402112455-c370050b (1).pdf
antiepilepticdrugs2-230402112455-c370050b (1).pdfantiepilepticdrugs2-230402112455-c370050b (1).pdf
antiepilepticdrugs2-230402112455-c370050b (1).pdf
 
Antiepileptic drugs
Antiepileptic drugs Antiepileptic drugs
Antiepileptic drugs
 
Summary of Product Monograph - Teva-levocarbidopa
Summary of Product Monograph - Teva-levocarbidopaSummary of Product Monograph - Teva-levocarbidopa
Summary of Product Monograph - Teva-levocarbidopa
 
ATYPICAL ANTI-PSYCHOTICS.pptx
ATYPICAL ANTI-PSYCHOTICS.pptxATYPICAL ANTI-PSYCHOTICS.pptx
ATYPICAL ANTI-PSYCHOTICS.pptx
 
Quetiapine
QuetiapineQuetiapine
Quetiapine
 
Paracetamol poisoning
Paracetamol poisoningParacetamol poisoning
Paracetamol poisoning
 

More from Neeraj Ojha

EIA.docx
EIA.docxEIA.docx
EIA.docx
Neeraj Ojha
 
CIB Nepali translation.docx
CIB Nepali translation.docxCIB Nepali translation.docx
CIB Nepali translation.docx
Neeraj Ojha
 

More from Neeraj Ojha (20)

EIA.docx
EIA.docxEIA.docx
EIA.docx
 
6. Solution mitigation of climate change.pptx
6. Solution mitigation of climate change.pptx6. Solution mitigation of climate change.pptx
6. Solution mitigation of climate change.pptx
 
5.Climate change and its impact on environment.pptx
5.Climate change and its impact on environment.pptx5.Climate change and its impact on environment.pptx
5.Climate change and its impact on environment.pptx
 
4BDirect and indirect health effects of climate change.pptx
4BDirect and indirect health effects of climate change.pptx4BDirect and indirect health effects of climate change.pptx
4BDirect and indirect health effects of climate change.pptx
 
1.concept of climate and weather.pptx
1.concept of climate and weather.pptx1.concept of climate and weather.pptx
1.concept of climate and weather.pptx
 
2,3 Greenhouse gases, global scenario, green house effectt and global warming...
2,3 Greenhouse gases, global scenario, green house effectt and global warming...2,3 Greenhouse gases, global scenario, green house effectt and global warming...
2,3 Greenhouse gases, global scenario, green house effectt and global warming...
 
8.1Determinants of Adaptive Capacity.pptx
8.1Determinants of Adaptive Capacity.pptx8.1Determinants of Adaptive Capacity.pptx
8.1Determinants of Adaptive Capacity.pptx
 
7.climate change vulnerability.pptx
7.climate change vulnerability.pptx7.climate change vulnerability.pptx
7.climate change vulnerability.pptx
 
4A Socio-economic and environmental impacts of climate change.pptx
4A Socio-economic and environmental impacts of climate change.pptx4A Socio-economic and environmental impacts of climate change.pptx
4A Socio-economic and environmental impacts of climate change.pptx
 
food word (1).docx
food word (1).docxfood word (1).docx
food word (1).docx
 
adaptive and innate immunity.pptx
adaptive and innate immunity.pptxadaptive and innate immunity.pptx
adaptive and innate immunity.pptx
 
Antibodies.pptx
Antibodies.pptxAntibodies.pptx
Antibodies.pptx
 
Activation and proliferating of B cell.pptx
Activation and proliferating of B cell.pptxActivation and proliferating of B cell.pptx
Activation and proliferating of B cell.pptx
 
Antigen-Antibody Reaction..pptx
Antigen-Antibody Reaction..pptxAntigen-Antibody Reaction..pptx
Antigen-Antibody Reaction..pptx
 
Antigen.pptx
Antigen.pptxAntigen.pptx
Antigen.pptx
 
CIB Nepali translation.docx
CIB Nepali translation.docxCIB Nepali translation.docx
CIB Nepali translation.docx
 
NEERAJ OJHA.docx
NEERAJ OJHA.docxNEERAJ OJHA.docx
NEERAJ OJHA.docx
 
acute appendicitis final.pptx
acute appendicitis final.pptxacute appendicitis final.pptx
acute appendicitis final.pptx
 
AADEE REMEDIES PVT. LTD, IMADOL, LALITPUR
AADEE REMEDIES PVT. LTD, IMADOL, LALITPURAADEE REMEDIES PVT. LTD, IMADOL, LALITPUR
AADEE REMEDIES PVT. LTD, IMADOL, LALITPUR
 
PHG 481 Traditional Systems of Medicine BPHARM syllabus PU
PHG 481 Traditional Systems of Medicine BPHARM syllabus PUPHG 481 Traditional Systems of Medicine BPHARM syllabus PU
PHG 481 Traditional Systems of Medicine BPHARM syllabus PU
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 

Recently uploaded (20)

MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
B.ed spl. HI pdusu exam paper-2023-24.pdf
B.ed spl. HI pdusu exam paper-2023-24.pdfB.ed spl. HI pdusu exam paper-2023-24.pdf
B.ed spl. HI pdusu exam paper-2023-24.pdf
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptxJose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
 
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
Operations Management - Book1.p  - Dr. Abdulfatah A. SalemOperations Management - Book1.p  - Dr. Abdulfatah A. Salem
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
 
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfDanh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
 
Salient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxSalient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptx
 
2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
NLC-2024-Orientation-for-RO-SDO (1).pptx
NLC-2024-Orientation-for-RO-SDO (1).pptxNLC-2024-Orientation-for-RO-SDO (1).pptx
NLC-2024-Orientation-for-RO-SDO (1).pptx
 

Carbamazepine

  • 1. Case Study on Carbamazepine Poisoning Neeraj Ojha Yuvraj Kalathoki 7th sem BPHARM
  • 2. INTRODUCTION Carbamazepine is a commonly prescribed agent for local epilepsy and other non epileptic conditions such as neuropathic pain ,schizophrenia and bipolar disorder in the pediatric and adult patients. It is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. The first overdose of carbamazepine was reported in 1967,and significant toxicity occurs at levels higher than 40 mg/L(usual therapeutic levels are 4 to 12 mg/L). Common etiology for carbamazepine toxicity is coadministration of other medications.
  • 3. Route of exposure Ingestion of the drug in large doses (drug overdose).
  • 4. Symptoms /Clinical features ● Drowsiness ● Slurred speech ● Ataxia ● Hallucinations ● Nausea and Vomiting ● Tremors ● Seizures ● Oliguria ● Blurred vision
  • 5. Mechanism of toxicity Carbamazepine and its active metabolite causes sodium channel blockade,causing slowed impulses in the brain .< It binds preferentially to voltage-gated sodium channel in their inactive conformation, which prevents repetitive and sustained firing of action potential.
  • 6. Etiology of toxicity Carbamazepine toxicity may result from acute overdose or chronic therapy .< Therapeutic levels are 4-12 mg/L Drug drug interaction are known to occur . Vander et al reported a case of carbamazepine toxicity that occurred after administration of oxybutynin and an increase in the dose of dantrolene. [9] The combination of these drugs elevated the level of carbamazepine, leading to toxicity.
  • 7. Treatment and Management Prehospital care/General management: ● Perform ABCD (Airway, Breathing, Circulation and Disability); ● Obtain intravenous (IV) access ● Place the patient on a cardiac monitor . ● Administer IV fluids if the patient is hypotensive . ● Administer activated charcoal if the patient has intact mental status and is able to protect the airway .
  • 8. Contd. Emergency Department care/Specific management for Chronic poisoning: ● Activated charcoal (if presents within 1 hour of ingestion).< ● Gastric lavage; Perform Gastric decontamination by Diuresis/Dialysis/Haemoperfusion/Peritoneal dialysis;
  • 9. CASE STUDY Detailed case study A 40 year male patient was referred to the emergency department of the hospital.He was admitted due to the ingestion of unknown pharmaceutical agent in an suicide attempt .THe patient has past medical history of epilepsy treated with carbamazepine and oxcarbazepine.The patient was in coma ,occasionally performing involuntary movements with his head arm and legs.
  • 10. Route of exposure Ingestion was the route through which toxic substance entered into the body.<
  • 11. Subjective detail ● Gender - male ● Age -40 yrs old ● Weight -65kg ● Hospital: XYZ
  • 12. Objective detail The normal range of carbamazepine is 4-12 mg/L.(therapeutic level).< The level of carbamazepine in patient was > 20ug/ml.< The patient was subjected to hemodialysis.The patient underwent a 4 hour hemoperfusion session followed by a hemodialysis session of 4 hour .
  • 13. Assessment The patient was diagnosed for the normal carbamazepine levels.< Hemoperfusion followed by hemodialysis was done to totally clear the high levels of carbamazepine.( 2 times the process was repeated).
  • 14. Planning ● Gastrointestinal decontamination with activated charcoal is commonly used. ● Hemoperfusion followed by hemodialysis was performed in combination. ● Supportive measures are to be considered. ● Symptomatic treatments are to be performed as soon as the patient reaches the hospital.
  • 15. Suggestions 1. Study suggests that dialysis techniques can be beneficial in a case of severe carbamazepine poisoning.<